Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2011 Jun;124(6):519-26.
doi: 10.1016/j.amjmed.2011.01.007.

Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies

Elaine W Yu  1 , Scott R Bauer, Paul A Bain, Douglas C Bauer
Affiliations
Meta-Analysis

Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies

Elaine W Yu et al. Am J Med. 2011 Jun.

Abstract

Background: Concerns have been raised about the risk of fractures with acid-suppressive medications, such as proton pump inhibitors and histamine(2)-receptor antagonists.

Methods: This meta-analysis evaluated the association between proton pump inhibitor or histamine(2)-receptor antagonist use and fractures. We performed a systematic search of published literature (1970 to October 10, 2010) in MEDLINE, EMBASE, and other sources. Ten publications reporting 11 studies were considered eligible for analysis.

Results: All studies were observational case-control or cohort studies and primarily evaluated older adults. The summary effect estimate for risk of hip fracture increased modestly among individuals taking proton pump inhibitors (relative risk [RR] 1.30, 95% confidence interval [CI], 1.19-1.43). There also was an increase in spine (RR 1.56, 95% CI, 1.31-1.85) and any-site fractures (RR 1.16, 95% CI, 1.04-1.30) among proton pump inhibitor users. These findings were similar in both men and women and after stratification by duration of use. In contrast, histamine(2)-receptor antagonist use was not significantly associated with increased risk of hip fracture (RR 1.12, 95% CI, 0.97-1.30).

Conclusion: In this meta-analysis of observational studies, proton pump inhibitors modestly increased the risk of hip, spine, and any-site fractures, whereas histamine(2)-receptor antagonists were not associated with fracture risk. The possibility of residual confounding cannot be excluded. Further skeletal evaluation should be considered for patients who are taking proton pump inhibitors and also at risk for osteoporotic fracture.

PubMed Disclaimer

Conflict of interest statement

Author attestations: None of the authors report any conflicts of interest. All authors had access to the data and a role in writing the manuscript.

Figures

Figure 1
Figure 1
Flowchart of the literature search
Figure 2
Figure 2
Association of PPI use and risk of fractures Analyses of the association between PPI use and risk of hip fractures, any fractures, and nonspine fractures. CI indicates confidence interval.
Figure 3
Figure 3
Association of H2RA use and risk of fractures Analyses of the association between H2RA use and risk of hip fractures and any fractures. CI indicates confidence interval.
See this image and copyright information in PMC

Comment in

References

    1. Top-line Industry Data. US Sales and Prescription Information. [Accessed July 5, 2010];IMS Health Incorporated. 2009 http://www.imshealth.com.
    1. Miyamoto M, Haruma K, Kuwabara M, Nagano M, Okamoto T, Tanaka M. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine. J Gastroenterol Hepatol. 2007;22(5):639–44. - PubMed
    1. Linsky A, Gupta K, Lawler EV, Fonda JR, Hermos JA. Proton pump inhibitors and risk for recurrent Clostridium difficile infection. Arch Intern Med. 2010;170(9):772–8. - PubMed
    1. Sarkar M, Hennessy S, Yang YX. Proton-pump inhibitor use and the risk for community-acquired pneumonia. Ann Intern Med. 2008;149(6):391–8. - PubMed
    1. Herzig SJ, Howell MD, Ngo LH, Marcantonio ER. Acid-suppressive medication use and the risk for hospital-acquired pneumonia. Jama. 2009;301(20):2120–8. - PubMed

Publication types

MeSH terms